Navigation Links
EpiStem Successfully Complete First Year of Mucositis Tests for NIH Biodefence Programme
Date:9/19/2007

pies is also developing its clinical diagnostic biomarker technology.

Combined Business Model

The Group is exploiting its combined business model to advance its own therapeutic candidates to late preclinical stage development. The business model integrates the discovery efforts of Novel Therapies with the efficacy testing assays of its Contract Research Services Division, to identify and characterise new drug candidates. Revenues generated by Contract Research Services will assist in offsetting Novel Therapies' investment requirements for the discovery and development of therapeutics. In February 2007, EpiStem licensed its first drug candidate to a clinical development company. With the validation of the Novel Therapies discovery platform and the achievement of discovery milestones, the Directors believe that additional licensing partnerships will be forthcoming for therapeutics, diagnostics and cosmeceuticals starting in 2008.

For more information please contact:

Matthew Walls

Chief Executive Officer

EpiStem Ltd

+44-(0)-161-606-7258

Mike Wort, Anna Dunphy

MC Bio-Communications Limited

+44-(0)-20-7744-7711

Thilo Hoffmann

Landsbanki Securities (UK) Limited

+44-(0)-20-7426-9000


'/>"/>
SOURCE Epistem Ltd
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. National Instruments DIAdem -- Complete Your Technical Data Management Framework with Powerful Off-line Analysis, Visualization, and Report Generation
2. Potawatomis complete acquisition of tech firm
3. Sonic Foundry completes $11.25M stock offer
4. Orion Energy completes $5M capital round
5. RedPrairie completes MARC acquisition
6. Metavante completes purchase of check processing firm
7. GE completes $1.2 billion acquisition
8. M & Is Metavante completes Brasfield Corp. acquisition
9. Berbee Data Centers complete audit, certification
10. Metavante completes GHR Systems acquisition
11. Metavante completes TREEV acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)NANJING, China, Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,("Simcere" or the "Company") (NYSE: SCR ), a leading pharmaceutical company,specializing in the development, manufacturing, a
(Date:12/2/2009)SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The world is going through,extraordinary times; markets are in turmoil and uncertainty is part of many,businesses and industries. It turns out that the pharma ind
(Date:12/2/2009)HOBOKEN, N.J., Dec. 2 According to the National Institute of Health, 40 percent to 45 percent of Americans diagnosed with diabetes already have some stage of diabetic retinopathy. Diabetic retinopat
(Date:12/1/2009)INCLINE VILLAGE, Nev., Dec. 1 PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced revenue guidance for the fourth quarter ended December 31, 2009 of approximately $57 million, as compared with
Breaking Biology Technology:Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3
...m F. Fearon, Morton J. Kern and Peter Ver ...ON, Massachusetts, October 8 The use of,fractiona...es is the topic,of multiple sessions at this year,...ium, TCT 2008, which will take place Oct. 12-17 in...t company to develop systems that,calculate FFR wi...
...l Corporation today,announced the appointment of t...porate Advisory Board (CAB). R. Christopher Seaton...rtha Matteo, Ph.D., Past President of,SCIP and rec...icals, Inc.,where she was the Director for Knowled... Advanced BioHealing, Inc., are known throughout t...
...fornia State Senator,Shelia Kuehl,s leadership rol...rominent Democrat to bring ,adult stem cell, resea...dicine (CIRM) as the viable and credible life,scie...The Repair Stem Cell,Institute (RSCI; http://www....voted,to educating the public about adult stem cel...
Other Biology Technology:Radi Medical Systems Announces Schedule for TCT 2008 2BioXcel Forms a Corporate Advisory Board for Its Next Phase of Growth 2California State Senator Shelia Kuehl's Leadership in Stem Cell Debate Praised and 'Embryonic Stem Cell Profiteers' Criticized by Repair Stem Cell Institute Spokesman 2
(Date:12/3/2009)Our ability to learn new information and adapt to changes in our daily environment, as well as to retain lifelong memories, appears to lie in the minute junctions where nerve cells communicate, accord
(Date:12/3/2009)ALBUQUERQUE, N.M. Most scientists believe that staph infections are caused by many bacterial cells that signal each other to emit toxins. The signaling process is called quorum sensing because many b
(Date:12/3/2009)Spanish researchers have measured CO2 levels for the past three years in the troposphere (lower atmosphere) over a sparsely inhabited rural area near Valladolid. The results, which are the first of th
Breaking Biology News(10 mins):Lifelong memories linked to stable nerve connections 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3CO2 levels rising in troposphere over rural areas 2CEL SCI Signs Definitive Agreement to Raise 245 Million in Registered Direct Offering 12761 1CEL SCI Signs Definitive Agreement to Raise 245 Million in Registered Direct Offering 12761 2CEL SCI Signs Definitive Agreement to Raise 245 Million in Registered Direct Offering 12761 3Veran Medical Enables Breakthrough 4D Navigation to Cancer Lesions at University of Virginia Hospital 49893 1Veran Medical Enables Breakthrough 4D Navigation to Cancer Lesions at University of Virginia Hospital 49893 2Bridges to Excellence Announces Five New Physician Recognition Programs With Potential to Save Billions of Health Care Dollars 49891 1Bridges to Excellence Announces Five New Physician Recognition Programs With Potential to Save Billions of Health Care Dollars 49891 2Bridges to Excellence Announces Five New Physician Recognition Programs With Potential to Save Billions of Health Care Dollars 49891 3
...TON, Sept. 8 The 2009 Force Protection Equipment,...County Regional Airport,Stafford, VA, and Marine C...VII theme is: Impacting the Global War on Terror.,...nd featuring live,presentations of commercial off-...ing force protection and physical security challen...
...ew paper by a team of researchers led by Shahriar ...s at the University of Notre Dame, provides import...a recycle their cell wall. , The cell wall is a c...ial for their survival. It is a rigid entity encas... interfere with disease processes by affecting its...
...YORK, September 8, 2008 Patients with type 1 diab...devices to help manage their disease experienced s...cording to initial results of a major multicenter ...earch Foundation. Results from the study were pres...e Study of Diabetes (EASD) annual meeting in Rome,...
Other Biology News:2009 Force Protection Equipment Demonstration Set for Next May 19-21 2JDRF-funded clinical trial demonstrates continuous glucose monitoring improves blood sugar control 2JDRF-funded clinical trial demonstrates continuous glucose monitoring improves blood sugar control 3
...gmaStat 3.5 is a user-friendly statistical softwar... them to perform statistical analysis without bein... about your data and research and SigmaStat sugges...st the tests underlying assumptions and suggests a...
...emiLucent™ Plus is a chemiluminescent signal...to boost the signal obtained with all ECL based We... is derived from a powerful, innovative proprietar...uminescent substrate enhancers, ChemiLucent™...
...ocess Control at its Best: DASGIPs Process Control...ring, Online Changes & comprehensive documentation...ters auch as pH, dissolved oxygen, temperature and...ine. Profiles, e.g. constant or scheduled media fl...
...P-165 is an 18 amino acid synthetic peptide whose ... The sequence of this peptide is (amino to carbox... - E - A - I - D - K - K - I - K - Q - D - C(39). ...control experiments with the polyclonal antibody t...
Biology Products: